Search Results
Site Search
Post-Bulletin Features Dr. Bobbi Pritt's "Creepy, Dreadful, Wonderful Parasites" Blog - Insights
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.
Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.
New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
Dr. Morice shares with Modern Healthcare how hospital-owned labs drive success - Insights
Dr. Morice highlights the crucial role of hospital-owned laboratories in enhancing patient care and hospital operations.
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
Dietrich Matern, M.D., Ph.D., Division Chair of Laboratory Genetics in the Department of Laboratory Medicine and Pathology in Rochester, Minnesota, has been appointed as a new director on the board of the American College of Medical...
Discontinuation of Herpes Simplex Virus (HSV) IgM Testing - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of...
Facebook Email or phone Password...
Allan Jaffe, M.D., Discusses Use of Highly Sensitive Cardiac Troponin in CAP Today - Insights
Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, spoke with CAP Today about what a new higher-sensitivity cardiac...
After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency...
Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. - Insights
John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.
It's inspection time: 5 key areas to prepare in your off-site waived testing locations - Insights
With all the preparations required to ready a clinical laboratory for regulatory inspection, it can be easy to overlook offsite testing locations, especially those performing CLIA-waived tests. Hospital laboratories with a CLIA Certificate...
Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...
Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, and Melissa...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
When the pandemic began, Mayo Clinic and its partners across the state worked tirelessly to ramp up testing, investigate treatment, and explore vaccine development.
Mayo Medical Laboratories and National University Hospital (NUH) in Singapore are now electronically linked via the widely used and secure Health Level 7 interface, enabling NUH to order specialized Mayo laboratory tests and receive patient...
Leslie Donato, Ph.D., Discusses New Lab Testing Options to Evaluate IBS-D Patients - Insights
Leslie Donato, Ph.D., Consultant in Cardiovascular Laboratory Medicine and Clinical Core Laboratory at Mayo Clinic, recently authored an article in "Medical Lab Management" on new laboratory testing options to evaluate irritable bowel...
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
People Archives - Page 7 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Surprises in Coagulation Testing - Insights
In this “Hot Topic,” William Nichols, M.D., presents a case study that demonstrates how pre- and postanalytic variables of the patient and blood samples can have confounding effects on the laboratory evaluation of coagulation disorders.
Jerry Katzmann, Ph.D., an emeritus consultant in the Mayo Clinic Protein Immunology Laboratory, has received the AACC Academy Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research.
People Archives - Page 11 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
MCL Combined Immunodeficiency Severe Combined Immunodeficiency BCellAntibody Deficiency Patient Information Complete print Reset Form Combined Immunodeficiency Severe Combined Immunodeficiency Cell Antibody Deficiency Patient Information...
On the Sept. 2 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Justin Kreuter, M.D., Medical Director of Mayo’s Blood Donor Program, about new eligibility guidelines for blood donors with previous...
Findings show 86 cases of COVID-19 in Minnesota associated with the rally, but notes that number underestimates the event's full impact in the state.
Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk...
MCL Cytogenetics Tech Only HER2 Paraffin Testing Patient Information MC1235203
MCL Cytogenetics Tech HER2 Paraffin Testing Patient Information Complete print Cytogenetics Tech HER2 Paraffin Testing Patient Information Patient Information Patient Middle Patient ID
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
HCV Treatment_(Interferon-Free).indd
05/2019© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Agent (DAA) Combination * www.hcvguidelines.org Treatment failure STOP...
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
Perspectives Archives - Page 3 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratories’ robust portfolio of clinically supported assays to test for marijuana use is consistent with professional recommendations.
Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights
This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.
Microlearning: All the Small Things - Insights
As the saying often goes, “It’s the small things that matter the most.” Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, discusses "microlearning" as a way of delivering learning content in...
sphingotec GmbH, a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may...
New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed...
Mayo Clinic MASSFIX - Insights
Learn more about matrix-assisted laser desorption/ionization-time of flight mass spectrometry and the identification of plasma cell disorders.
MCL Brutons Tyrosine Kinase BTK Genotype Patient Information MC1235132
MCL Brutons Tyrosine Kinase BTK Genotype Patient Information Complete print Bruton Tyrosine Kinase BTK Gene Sequencing Patient Information Reset Form Instructions accurate interpretation reporting
Malaria Laboratory Testing.indd
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2021 Malaria Laboratory Testing Algorithm 1 Malaria can be a rapidly fatal disease, particularly when due to Plasmodium falciparum, and less commonly...
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 27 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.
Mayo Clinic Laboratory and Pathology Research Roundup: April 9 - Insights
This week’s Research Roundup highlights genetic evidence for early peritoneal spreading in pelvic high-grade serous cancer.
Mayo Clinic Laboratories offers the industry’s most comprehensive therapeutics test menu. Developed by experts to align with governmental and professional recommendations, our assays combine cutting-edge methodologies with precision...
Frequently asked questions - Insights
For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...
Frequently asked questions - Insights
For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...
The diagnosis of Myeloproliferative Neoplasm (MPN) must include an integrated approach and combine the clinical findings with laboratory results. In our latest “Hot Topic,” Rong He, M.D., discusses the subclassification of MPNs and the use...
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2024 Assessment for Zika Virus Infection * For pregnant women who have a fetus with prenatal ultrasound findings consistent with congenital Zika virus...
Lung Cancer NGS Panel - Mayo Clinic Laboratories
Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.
Online education and training provided through pre-recorded presentations and interactive learning modules.